The treatment of hyperkalemia, which included calcium gluconate 10 ml of a 10% solution administered intravenously, insulin glucose infusion (IGI; short acting insulin at 10 IU in 250 ml %10 glucose, 50 ml/h ventolin inhaler (10-20 mg dose in 4 ml saline delivered by a nebulizer) and sodium polystyrene sulfonate (3x15 g/day, was commenced. This evidence concerns the gene INS and Hyperkalemia.